“Get your affairs in order; we have to treat immediately; average survival rate is 6 years” – those were jarring words for someone in his early 40s to hear . Read more.
My life so far has been an exciting journey, punctuated by a cascade of medical events. Never a dull moment. Read more.
Pharmacyclics announces that, due to feedback from the recently announced rollout of a once-a-day tablet of Imbruvica, it will continue to offer the original 140 mg capsules.
Making Strides for WMers Worldwide: Support the 2nd Annual Walk for Waldenstrom’s on Sunday, May 20, 2018!
On June 27th, Dr. Jorge Castillo of Dana-Farber Cancer Institute and Dr. Morie Gertz of the Mayo Clinic will give a talk on “Progress in the Treatment of WM.”
The 2018 IWMF About Waldenstrom’s Macroglobulinemia – Details Fact Sheet provides an overview of WM, just right for friends and family who may be unfamiliar with the disease.
Now in its third revision, the IWMF 2018 booklet explains the basic concepts of immunology and genetics as they pertain to WM.
The IWMF is pleased to announce the establishment of the IWMF Support Group-China. The newest IWMF Affiliate, under the leadership of Roger Yao, will be based in Shanghai.
The US Food and Drug Administration (FDA) has approved multiple strength versions of dosing tablets, which will replace the original 140 mg capsule.
This one-hour educational program on advances in research and quality of life issues for patients with WM, features Dr. Stephen Ansell of the Mayo Clinic, Rochester